Premium
Systemic lupus erythematosus‐associated anetoderma and anti‐phospholipid antibodies
Author(s) -
FernándezGalar M.,
España A.,
Lloret P.
Publication year - 2003
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1046/j.1365-2230.2003.01139.x
Subject(s) - medicine , antibody , pathogenesis , lupus erythematosus , systemic disease , connective tissue disease , phospholipid , dermatology , systemic lupus erythematosus , immunology , immunopathology , pathology , autoimmune disease , disease , membrane , biology , biochemistry
Summary Anetoderma is characterized by a loss of normal elastic tissue that presents clinically as localized areas of wrinkled or flaccid skin. We describe the case of a 30‐year‐old woman with systemic lupus erythematosus‐associated anetoderma and positive anti‐phospholipid antibodies. We discuss the possible role of these antibodies in the pathogenesis of anetoderma, and, when detected, the need to check for an associated anti‐phospholipid syndrome in such patients.